Completed
Phase I Study of Intrathecal Mafosfamide
NCT00001251
- Conditions
- Central Nervous System Neoplasms, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States